Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Sirona Biochem Corp V.SBM

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  SRBCF

Sirona Biochem Corp is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France.
Price: $0.14 | Change: $-0.01 | %Change: -6.67%
Volume: 524,000 | Day High/Low: 0.145/0.135 | 52 Week High/Low: 0.205/0.085

Snapshot

Last Traded: September 17, 2014 11:51 Transaction Volume: 524,000
Open: $0.14 Previous Close: $0.15
Bid: $0.135 Ask: $0.14
Bid Size: 100,500 Ask Size: 25,000
Market Cap: $17.4m Shares Out: 124.5m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Haywood snaps up 10,000 BiOasis shares (V.BTI)

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   September 30, 2013
0 stars

Latest Bullboard Posts

  • RE:RE:RE:RE:think

    1 star

    lscfa u should be quiet now/ u r writing what u r thinking/mani------

    2 stars


  • RE:RE:RE:RE:think

    1 star

    that's tho only way sbm can if (manmade)

    2 stars


  • RE:RE:RE:think

    5 stars

    Again you show your stupidity diamondless.  You can not infer investor sentiment from short term movements in a stock price, especially a...

    3 stars


  • RE:RE:think

    1 star

    I c u give urself a 5 star /y is the stock going down when revenue is coming in/ u c the smart people got out.

    2 stars


  • RE:think

    5 stars

    You really are stupid diamondless. No need for a rollback since revenues starting to flow and financings not required.

    3 stars